September 29, 2017 / 2:23 AM / 3 months ago

BRIEF-Hybio Pharmaceutical gets approval for drug clinic trials

Sept 29 (Reuters) - Hybio Pharmaceutical Co Ltd

* Says it received clinic trials approval of two drugs for treatment of osteoporosis and glycemic control of diabetes, from China Food and Drug Administration

Source text in Chinese:goo.gl/hnGVej

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below